Esperion Therapeutics ESPR Property, plant and equipment at cost
Property, plant and equipment at cost at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.
The official record: Esperion Therapeutics’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's property, plant and equipment at cost.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's property, plant and equipment at cost?
- Esperion Therapeutics (ESPR) reported property, plant and equipment at cost of $2.52M in Q4 2025.
- How has Esperion Therapeutics's property, plant and equipment at cost changed year-over-year?
- Esperion Therapeutics's property, plant and equipment at cost increased by 8.1% year-over-year, from $2.33M to $2.52M.
- What is the long-term trend for Esperion Therapeutics's property, plant and equipment at cost?
- Over 5 years (2020 to 2025), Esperion Therapeutics's property, plant and equipment at cost has grown at a -2.4% compound annual growth rate (CAGR), from $2.85M to $2.52M.